Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Furan Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111303083A reveals a green hydroaminocarbonylation route for 3-aminomethyl tetrahydrofuran. Achieve cost reduction in agrochemical intermediate manufacturing with scalable, high-purity production.
Patent CN112159375B details a catalyst-free aqueous halocyclization route for 2,3-dihydrofurans, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN118373865B details a high-yield nucleoside intermediate route offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis of 1 2 3-O-triacetyl-5-deoxy-D-ribofuranose via patent CN102432642A. Delivers high purity, safety, and cost reduction in antitumor drug manufacturing.
Patent CN1066658A details efficient asymmetric synthesis of antiviral furanoside intermediates, offering scalable routes for HIV therapeutic manufacturing.
Patent CN114044766B details a novel route for C-14 labeled dinotefuran. This report analyzes cost-effective synthesis strategies for metabolic research intermediates.
Patent CN107935970A enables high-purity low-water 3-methylamine tetrahydrofuran production. Significant cost reduction and supply chain reliability for dinotefuran manufacturing intermediates.
Advanced synthesis of hexahydrofuro[2,3-b]furan-3-ol via patent CN103864813A. Offers cost reduction in API manufacturing and reliable supply chain for pharmaceutical intermediates.
Novel Rh-catalyzed one-pot route for spiro-oxindoles. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for oncology drug development.
Advanced preparation of 2-butyl benzofuran via carbonate-catalyzed cyclization. High-purity amiodarone intermediate manufacturing with simplified downstream processing.
Novel gamma-butyrolactone route for 3-hydroxymethyl tetrahydrofuran. High yield, low cost agrochemical intermediate manufacturing process suitable for industrial scale-up.
Novel synthesis route for Amiodarone intermediate offering high selectivity and cost efficiency for pharmaceutical supply chains ensuring reliable delivery and quality.
Patent CN1229366C reveals a superior 3-step route for Dronedarone intermediates, offering reduced waste and higher yields for reliable pharmaceutical supply chains.
Novel synthesis of (R)-4-propyl dihydrofuran-2-one via Meldrum's acid. High optical purity, scalable route for Brivaracetam intermediates. Cost-effective manufacturing solution.
Patent CN110372641B reveals a novel enzymatic route for hexahydrofurofuranol derivatives, offering high optical purity and cost-effective manufacturing for API supply chains.
Patent CN113402490B reveals a cost-effective 5-step route for Ramelteon intermediates, offering significant supply chain stability and purity advantages.
Patent CN110669027B discloses efficient synthesis of tetrahydrofuran carboxylic acid intermediates for prostate cancer drugs, offering scalable routes and reduced purification costs.
Patent CN1306000A reveals a novel synthesis for a key Dronedarone intermediate, offering improved purity and simplified purification for pharmaceutical supply chains.
Patent CN1732149A details a scalable Claisen rearrangement for 3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-2-one, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN104557815A reveals high-purity isotope-labeled methyl furanone synthesis. Enhances GC-MS accuracy for strigolactone analysis with stable labeling.